Skip to content

Pharmacy

Upsher-Smith, NASPA honor pharmacists

Upsher-Smith, NASPA honor pharmacists

Upsher-Smith Laboratories Inc. and the National Alliance of State Pharmacy Associations (NASPA) have recognized 43 pharmacists from across the country with a 2015 NASPA Excellence in Innovation Award.

Mylan to acquire Meda in $9.9 billion deal

Mylan to acquire Meda in $9.9 billion deal

Mylan N.V. plans to acquire Sweden-based pharmaceuticals manufacturer Meda AB in a deal valued at $9.9 billion, including debt. Mylan said late Wednesday that the offer to Meda includes cash and Mylan shares, with the equity portion valued at $7.2 billion.

Promius Pharma to release Sernivo Spray

Promius Pharma to release Sernivo Spray

Promius Pharma LLC has received Food and Drug Administration approval for Sernivo Spray 0.05%, a psoriasis medication. A prescription topical steroid, Sernivo Spray (betamethasone dipropionate 0.

Walgreens sharpens aim at drug abuse

Walgreens sharpens aim at drug abuse

Aligning with public- and private-sector efforts to fight drug abuse, Walgreens plans to make opioid-overdose antidote naloxone available without a prescription in most of its stores and deploy medication disposal receptacles in hundreds of stores.

Administration keeps tinkering with ACA

Administration keeps tinkering with ACA

The Obama administration continues to alter the Affordable Care Act and propose changes to Medicaid funding as it seeks to increase the number of Americans who have health insurance and slow the pace of medical cost ­inflation.

Leger tabbed to head pharmacy at SDM, Loblaw

Leger tabbed to head pharmacy at SDM, Loblaw

Jeff Leger has been named executive vice president of pharmacy and health care for both Loblaw and Shoppers Drug Mart stores. He had been senior vice president of Loblaw pharmacy and pharmaceutical partnerships. Leger took the new role following the departure of Dr.

BI rolls out Spiriva Respimat asthma inhaler to pharmacies

BI rolls out Spiriva Respimat asthma inhaler to pharmacies

Boehringer Ingelheim Pharmaceuticals Inc. has released Spiriva Respimat, an asthma treatment, to U.S. pharmacies. BI noted that Spiriva Respimat isn’t a medication for sudden asthma symptoms. The Food and Drug Administration approved a once-daily dose of Spiriva Respimat 2.